News
Media
Conference
Publications
Resources
Partners
Subscribe

Spotlight -

Geographic Atrophy

ASRS

CEO of Aerie Pharmaceuticals provides a brief company overview at OIS meeting

August 14th 2018

Global trends in retina: How surgeons are practicing in 2018

ByMichelle Dalton, ELS

July 24th 2018

Oral therapy may be viable for CSC

ByMichelle Dalton, ELS

July 23rd 2018

Fellows report increasing surgical experience during training

ByMichelle Dalton, ELS

July 23rd 2018

Why microscope-integrated OCT is vital to gene therapy

ByMichelle Dalton, ELS

July 23rd 2018

Numerous advances in diabetic eye disease, but many questions remain

ByMichelle Dalton, ELS

July 22nd 2018

What makes pneumatic vitreolysis 'highly effective' for VMT

ByMichelle Dalton, ELS

July 22nd 2018

What APL-2 means for geographic atrophy

ByMichelle Dalton, ELS

July 21st 2018

How AMD patients are treated in the 'real world'

ByMichelle Dalton, ELS

July 21st 2018

Brolucizumab: Next-generation of anti-VEGF therapy?

ByMichelle Dalton, ELS

July 21st 2018

Trending on Modern Retina

Belite Bio initiates rolling NDA submission for tinlarebant in Stargardt disease type 1

CONDOR clinical trial: Brolucizumab superior to panretinal photocoagulation for proliferative diabetic retinopathy

Additional SOL-1 analyses show delayed CSFT worsening with AXPAXLI